Richard Lim
SlowingNamed in filings at Cure VenturesOn the current fund
- Board seats filed
- 13
Named in filings at Cure VenturesOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Alessa Therapeutics | Biotech & pharma | April 2025 | None on file |
| Medable | Digital health | April 2020 | None on file |
| Sparta Software | Digital health | February 2020 | Playground Global |
| Loop Now Technologies | E-commerce & marketplaces | January 2020 | None on file |
| MobiSocial | Consumer apps & internet | March 2018 | None on file |
| Gossamer Bio | Biotech & pharma | January 2018 | ARCH Venture Partners |
| Deep 6 AI | Digital health | November 2017 | None on file |
| ZingBox | Cybersecurity | July 2017 | None on file |
| KINSA | Digital health | December 2016 | Kleiner Perkins, Westlake Biopartners |
| Rulai | Enterprise software | June 2016 | None on file |
| PIPER THERAPEUTICS | Biotech & pharma | May 2016 | None on file |
| PARATEK PHARMACEUTICALS | Biotech & pharma | June 2014 | Abingworth Bioventures |
| TRIDENT PHARMACEUTICALS | Biotech & pharma | May 2014 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Richard Lim on the board, based on 13 filed seats with a verified or cited source.